Sig Brokerage »

Galectin Therapeutics shares owned by Sig Brokerage

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sig Brokerage from 13F filings

Historical chart of Sig Brokerage investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Sig Brokerage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Sig Brokerage

Quarter filed Position value Share count Share price at filing
2025-09-30 $67k 16k 4.24

More positions owned by Sig Brokerage

Meta Platforms Cl A Put Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Oracle Corporation (ORCL)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Apollo Global Mgmt Call Option (APO)
Booking Holdings (BKNG)
Ishares Msci Brazil Etf (EWZ)
Arm Holdings Sponsored Ads Call Option (ARM)
Coreweave Com Cl A (CRWV)
Thermo Fisher Scientific Call Option (TMO)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
UnitedHealth Put Option (UNH)

View all positions for Sig Brokerage

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Geneos Wealth Management
Commonwealth Equity Services
Vivaldi Capital Management
State Street Corporation
Morgan Stanley
Retirement Guys Formula
Sovran Advisors

View all funds holding Galectin Therapeutics